About this trial
To explore the feasibility of Jefcare Sterile Medical Sheets in preventing incontinence-associated dermatitis and maintaining a stable local skin microclimate in adult patients in the intensive care unit.
Eligibility criteria
Qualifiers
Intensive care unit incontinent patients (incontinence time ≥2 days)
Age ≥18 years
patients at high risk of IAD (Perineal Assessment Tool ≥ 7)
Voluntarily participate in the study and sign an informed consent form. If the subject is unable to read and sign the informed consent form due to incapacitation or other reasons, their guardian is required to represent the informed process and sign the informed consent form. If the subject is unable to read the informed consent form (e.g., illiterate subjects), a witness will be required to witness the informed process and sign the informed consent form.
Disqualifiers
Patients who have developed IAD
Expected subsequent stay in the intensive care unit <5 days
Use of nappies, pull-ups, incontinence pads, etc.
Simple urinary incontinence with indwelling catheterization, external urinary bag without leakage; simple fecal incontinence with built-in drainage device, external ostomy bag, OB tampon without leakage; double incontinence with indwelling catheterization, external urinary bag, built-in drainage device, external ostomy bag, OB tampon without leakage.
Trial design
Treatments tested in this trial
- Jefcare Sterile Medical Sheets
- Molicare Premium Bed Mat
Treatment groups
Locations
Sponsors and collaborators
Sir Run Run Shaw Hospital
Lead sponsor
Shaoxing People's Hospital
Collaborator
Jiangshan People's Hospital
Collaborator